ane 510 pharmacology i instructor: ron dick, r.ph., ph.d. office: 130 snhs telephone: 899-3365...

32
ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: [email protected] Office Hours: Monday 9-12, Tuesday 1-3 or

Upload: poppy-gibson

Post on 17-Jan-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

ANE 510Pharmacology I

Instructor: Ron Dick, R.Ph., Ph.D.

Office: 130 SNHS

Telephone: 899-3365

E-Mail: [email protected]

Office Hours: Monday 9-12,

Tuesday 1-3 or

By Appointment

Page 2: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Introduction

• Course syllabus and rules• Textbooks

–Required:• Stoelting, R.K., Pharmacology and Physiology

in Anesthetic Practice, 2006, 4th Ed.• Kier and Dowd, The Chemistry of Drugs for Nurse Anesthetists, 2004, 1st Ed.

–Recommended: • Brunton et al, Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 2006, 11th Ed.• Evers, A.S. and Maze, M., Anesthetic Pharmacology: Physiologic Principles and Clinical Practice, 2004, 1st Ed.

–Course Information and Materials• Blackboard

Page 3: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Basic Drug Chemistry Review

• Drug Chemistry– Chirality (D and L pairs)

• Chiral refers to molecule with a center of three-dimensional asymmetry. • > 50% of all drugs are chiral (enantiomeric pairs)• Enantiomers (molecules having opposite shapes) are pairs of molecules existing in forms that are mirror images of each other (right-& left-hand) but that cannot be superimposed.

– Structure Activity Relationship (SAR)• Understanding the relationship between drug structures and biological activities forms the basis of rational drug design. • Computer-enhanced molecular modeling and information concerning three-dimensional receptor structure may combine to improve the effectiveness of rational drug design approaches.

Page 4: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Basic Pharmacology Review

• Drug Chemistry– Three major types of chemical forces/bonds:

• Covalent--very strong– Frequently "irreversible" under biological conditions – Example - DNA-alkylating chemotherapy drugs

• Electrostatic:-- weaker than covalent– More common then the covalent bonding in drug-receptor interactions – Strong: interactions between permanently charged ionic molecules

• Weaker: hydrogen bonding • Still weaker: induced-dipole interactions, e.g. van der Waals forces • Hydrophobic interactions: generally weak

– probably significant in driving interactions:– between lipophilic drugs and the lipid component of biological membranes – between drugs and relatively nonpolar (not charged) receptor regions

Page 5: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Basic Pharmacology Review

• Drug Chemistry– Henderson-Hasselbach equation

• pH = pKa + log [Ionized]/[Unionized]

• useful for determining how well an ionizable drug will cross biological membranes.

• most drugs are weak bases (RNH3+ RNH2 + H+) or weak

acids (RCOO- + H+ RCOOH).• lipid diffusion depends on adequate lipid solubility.• drug ionization reduces a drug's ability to cross a lipid bilayer.

Page 6: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Henderson-Hasselbach

Page 7: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Basic Pharmacology Review

• What is Pharmacology?

• What is a drug?– Mimics endogenous ligand (usually)

• Where do drugs act?

• How much is enough or too much?

• How is a drug best given?

Page 8: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Drug Fate in the Body

Page 9: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Drug Disposition

Page 10: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Definitions

• Pharmacodynamics– The effects of a drug on the body.

– Relates the drug concentration to its effect.

• Pharmacokinetics– Relationship between drug dose and tissue conc.

– Involves ADME processes

Page 11: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Definitions

• Agonist– A substance which interacts at a receptor to elicit a response.

• Antagonist– A substance which blocks the response of an agonist at

a receptor.– Different types

• Competitive• Non-competitive• Negative Antagonists (inverse agonists)• Partial Agonist/Antagonist

Page 12: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Neurotransmission Review

• Review of basic neurotransmission– Cell body (soma)– Dendrites– Axon hillock– Axon– Nerve terminal

• Post Synaptic Receptors

Page 13: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Receptors

• Usually named for the agonist and antagonist which the interact with.

– Examples:• Cholinergic receptors interact with acetylcholine• Adrenergic receptors interact with norepinephrine• GABA receptors interact with gamma amino butyric acid

• Receptor locations:– Cell membrane (inside and outside)– Cell cytoplasm– Nuclear envelope

Page 14: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Receptor Types

Page 15: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Nature of Receptors

• Responsible for the transduction of biologic signals.

• Cellular components (usually) that interact with other molecules to elicit some effect.

• Effect may be some biologic response, or a biochemical change that eventually produces some effect.

• Not all drugs exert their effects via a receptor-mediated response.

Page 16: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Nature of Receptors

• Non-Receptor Mediated Examples– Mannitol – an osmotic diuretic.– Methyl cellulose - an osmotic laxative.– Dextrans – when used IV, expand blood

volume by pulling water from tissues into blood.

Page 17: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Nature of Receptors

• Many enzymes have been shown to be specific drug receptors (ex.- digitalis acts on Na+/K+ ATPase in heart muscles to increase force of contractions).

• Nucleic acids (ex.- DNA) can act as receptors to some compounds such as the antibiotic Actinomycin D.

• Other membrane components, such as fungal ergosterol, can bind agents (ex.- Amphotericin B).

Page 18: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Nature of Receptors

• Due to required fit at binding site, alterations in ligand structure will effect ligand affinity and/or intrinsic activity (SAR).

• Most drugs act on receptors, except:– Some anesthetics, hypnotics, and sedatives– Alcohols– Osmotically-active drugs– Acidifying/alkalinizing agents– Antiseptics

Page 19: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Nature of Receptors

• Receptors can be blocked by receptor antagonists (affinity, but low-to-no intrinsic activity).– For example, Atropine blocks muscarinic Ach

receptors.

• Usually, nonspecific receptors (such as those for ethanol) require high drug concentrations for effect (millimolar to molar), whereas specific receptors require only low concentrations (nanomolar to millimolar).

Page 20: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Receptor Binding

Page 21: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Receptor Binding States

Page 22: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Gap Junctions

Page 23: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Receptor Agonists

Page 24: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Receptor Occupancy

Page 25: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Receptor Antagonists

Page 26: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Receptor Antagonists

Page 27: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Receptor Signaling

Page 28: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office
Page 29: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Drug/Receptor Binding

• D + R DR

• The affinity of drug binding is referred to as the association constant, KA

– This is defined as: KA = kon/koff.

– The dissociation constant (KD), is the concentration at which 50% of the receptors are occupied, and is equal to 1/KA (or koff/kon).

Page 30: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Dose-Response Curve

Page 31: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Drug Potency

Page 32: ANE 510 Pharmacology I Instructor: Ron Dick, R.Ph., Ph.D. Office: 130 SNHS Telephone: 899-3365 E-Mail: rdick@mail.barry.edurdick@mail.barry.edu Office

Receptor Sensitivity